Piper Sandler raises Nevro stock to Neutral, cuts target to $5.85
Piper Sandler analyst Adam Maeder upgraded shares of Nevro Corp (NYSE:NVRO), a medical device company with a market capitalization of $214 million, to Neutral from Underweight and adjusted the price ...
UBS cuts FMC stock rating to neutral, slashes price target to $38
UBS analyst Joshua Spector downgraded shares of FMC Corp . (NYSE: NYSE:FMC) from Buy to Neutral, significantly reducing the price target from $66.00 to $38.00. The adjustment reflects concerns over ...